2024 has been another milestone year for the data center industry. Records were broken for mergers and acquisitions at the ...

Federal Home Loan Mortgage Corporation (Freddie Mac) may see big gains with privatization. Find out why FMCC stock could be a ...

The domestic startup ecosystem is expected to rebound with fresh approaches in key sectors like content, media, fintech, and ...

Trump, a newly appointed advisor to GrabAGun, will become an equity holder once the transaction closes this summer. Although ...

North American venture funding spiked in the final quarter of 2024, closing out an up year for startup investment driven by ...

Simpson Thacher partners offer IPO tips for private companies, noting that having an independent board and the correct ...

Nice One Beauty Digital Marketing Co. surged in its debut after a $320 million initial public offering in Riyadh, the latest ...

DraftKings, a powerhouse in the sports betting industry, has launched an enticing new service that enhances odds for parlay ...

Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its ...

Drug developer Maze Therapeutics Inc.'s rollercoaster ride is leading to the Bay Area's first biotech IPO filing of 2025.

After forming through the merger of three companies last summer, a Houston-based oil field services provider is going public.

The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...